Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Lewy Body Dementia Market Growth From $1.29 Billion In 2026 To $1.69 Billion By 2030 At A CAGR Of 6.9%
The lewy body dementia market has seen significant expansion in recent years. It is projected to increase from $1.2 billion in 2025 to $1.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. The historical growth in this market stems from an aging global population, better recognition of various dementia subtypes, more frequent use of neurological examinations, the proliferation of hospital-based diagnostic services, and a heightened clinical focus on cognitive decline.
The Lewy body dementia market size is anticipated to undergo significant expansion over the next few years, projected to reach $1.69 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This growth throughout the forecast period can be primarily attributed to improved diagnostic accuracy, the escalating burden of chronic neurological diseases, the enlargement of specialty clinic networks, increased support programs for caregivers and patients, and elevated healthcare spending dedicated to dementia care. Prominent trends expected during this period include a rising prevalence of neurodegenerative disorders, enhanced awareness and prompt recognition of LBD, a growing demand for accurate differential diagnosis, the expansion of symptom-specific drug utilization, and an increasing need for long-term care and effective disease management.
Get A Free Sample Report With In-Depth Market Insights:
Lewy Body Dementia Market Development Factors: What’s Supporting Demand?
An increase in the occurrence of brain-related conditions is projected to drive the expansion of the lewy body dementia market moving ahead. These disorders encompass various ailments impacting the brain’s structure and how it functions, resulting in impaired cognition, loss of memory, and altered behaviors. The growing frequency of brain-related disorders stems from factors like advancing age, genetic susceptibility, and influences from the environment. This rising prevalence of brain conditions heightens the need for improved treatments and prompt detection of lewy body dementia, which subsequently stimulates research, investment, and innovative solutions, thereby accelerating progress in LBD diagnosis and treatment. For example, data from October 2023, provided by the World Federation of Neurology, the UK-based association of national neurological societies, indicated that over 40% of the worldwide populace suffers from neurological conditions, a burden anticipated to nearly double by 2050. Consequently, the escalating incidence of brain-related conditions will fuel the expansion of the lewy body dementia market.
Lewy Body Dementia Market Breakdown By Product Type And Application
The lewy body dementia market covered in this report is segmented –
1) By Diagnosis: Clinical Diagnosis, Biomarker-Based Diagnosis
2) By Medication: Cholinesterase Inhibitors, Antipsychotics, Antidepressants, Other Medications
3) By End-User: Hospitals, Specialty Clinics, Long-Term Care Facilities, Other End-Users
Subsegments:
1) By Clinical Diagnosis: Neuropsychological Testing, Neurological Examination, Medical History Review, Cognitive Function Assessment
2) By Biomarker-Based Diagnosis: Cerebrospinal Fluid (CSF) Biomarkers, Imaging Biomarkers (PET, MRI)
Lewy Body Dementia Market Transformation Trends: What Innovations Are Driving Change?
Leading companies within the lewy body dementia market are concentrating on investing in research to develop more effective neurodegenerative treatments. Research investment involves allocating financial resources, time, and effort towards scientific and technological studies with the goal of discovering new insights, creating innovative solutions, or improving current practices. This supports the investigation of diseases and the development of new medications, all ultimately aimed at enhancing patient outcomes. For example, in March 2023, the National Institute on Aging, a US-based government agency, provided $21 million in funding to support drug development research for Lewy Body Dementia (LBD). Researchers at the University of Miami Miller School of Medicine are beginning a Phase 2b study of neflamapimod after receiving encouraging initial results.
Lewy Body Dementia Market Company Landscape And Competitive Strategy
Major companies operating in the lewy body dementia market are Eli Lilly and Company, Mayo Foundation for Medical Education and Research, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Georgetown University Medical Center, Alzheimer’s Society, BioArctic AB, Annovis Bio Inc., Sun Pharma Advanced Research Company Limited, Voyager Therapeutics Inc., Cognition Therapeutics, Athira Pharma, Allergan plc, Inhibikase Therapeutics, CuraSen Therapeutics Inc., CervoMed Inc., AC Immune SA, ProMIS Neurosciences Inc., Aptinyx Inc., EIP Pharma Inc.
View The Full Lewy Body Dementia Market Report:
Lewy Body Dementia Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the lewy body dementia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lewy body dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









